Logo Logo

Category Archives: "News"

  1. Home
  2. CMSC PR
  3. Page 18
May 30, 2017
CMSC 2017 Annual Meeting – Cladribine reduced annual multiple sclerosis relapse rate by 55% to 57%, trials show
CMSC PR
Cladribine tablets reduced relapsing multiple sclerosis patients’ annual relapse rate by 55 to 57 percent, depending on the dose, [...]
Elizabeth Porco
Read More
...33
0
May 30, 2017
CMSC 2017 Annual Meeting – review suggests certain multiple sclerosis patient groups may discontinue DMTs
CMSC PR, Partners
Older patients with secondary progressive multiple sclerosis (SPMS) as well as older relapsing patients whose MS has been inactive after [...]
Elizabeth Porco
Read More
...38
0
May 26, 2017
CMSC 2017 Annual Meeting – Tysabri improves mental outlook for patients with secondary progressive MS
CMSC PR, Partners
Long-term therapy with Tysabri (natalizumab) significantly improved the mental state of people with secondary progressive multiple [...]
Elizabeth Porco
Read More
...42
0
May 26, 2017
CMSC 2017 Annual Meeting – feeling of social stigma makes depression in multiple sclerosis more likely, study reports
CMSC PR
People with multiple sclerosis (MS) who feel stigmatized because of their condition are more likely to have depression, research presented [...]
Elizabeth Porco
Read More
...36
0
May 26, 2017
CMSC 2017 Annual Meeting – multiple sclerosis patients should contribute to outcome measure development, study argues
CMSC PR, Partners
Patients must help develop new outcome measures of multiple sclerosis (MS), since they and healthcare providers may have differing [...]
Elizabeth Porco
Read More
...37
0
May 26, 2017
CMSC 2017 Annual Meeting – multiple sclerosis mobile apps link clinicians and patients, improving disease management
CMSC PR
The use of multiple sclerosis (MS) mobile apps by patients and their clinicians encourages shared decision-making and helps patients [...]
Elizabeth Porco
Read More
...37
0
May 26, 2017
CMSC 2017 Annual Meeting – relapse after first Lemtrada course no indication of poor long-term outcome
CMSC PR
Multiple sclerosis (MS) patients who experienced a relapse between their first and second rounds of Lemtrada (alemtuzumab) had good [...]
Elizabeth Porco
Read More
...37
0
May 26, 2017
CMSC 2017 Annual Meeting – single session of ball-throwing exercise improves balance control in multiple sclerosis
CMSC PR, Partners
Patients with relapsing-remitting multiple sclerosis (RRMS) regain part of their balance control after a single training session of [...]
Elizabeth Porco
Read More
...40
0
May 26, 2017
CMSC 2017 Annual Meeting – Genentech starts site to connect multiple sclerosis patients and caregivers with resources
CMSC PR, Partners
Genentech has rolled out a website to connect multiple sclerosis (MS) patients and caregivers with resources that can help [...]
Elizabeth Porco
Read More
...37
0
May 20, 2017
Multiple sclerosis study in cancer breakthrough
INforMS
A DRUG that helps the immune system destroy cancer has been developed by US scientists. It dramatically shrank deadly skin, brain and [...]
Elizabeth Porco
Read More
...36
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM